Analysis of RAS mutation in thyroid nodular hyperplasia and follicular neoplasm in a Korean population.
Sun Hye JeongHyun Sook HongEun Hye LeeJeong Ja KwakJi Ye LeePublished in: Endocrinology, diabetes & metabolism (2018)
The frequencies of RAS mutations among our Korean population were 18% in NHs, 46.2% in FTC and 33.3% in FTAs. N-RAS codon 61 was the most frequent mutation in NHs, FTCs and FTAs, and the frequency was not significantly different among the three groups. K-RAS codons 12-13 were the second most commonly involved site in FTCs and FTAs, whereas no mutation was detected at this site in NHs.